The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Antimicrobial susceptibility profiles of oral Treponema species
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Minocycline, known for its broad‐spectrum antibacterial activity against periodontal pathogens, is a commonly used antibiotic in the treatment of periodontal disease. 23”
From Facile minocycline deployment in gingiva using a dissolvable microneedle patch for the adjunctive treatment of periodontal disease (2025) · cites this paper as [23]
In the citing paper
“It has been documented that the minimal inhibitory concentration (MIC) of MINO against Treponeme is less than 0.125 μg/mL (Okamoto-Shibayama et al., 2017) and against Actinobacillus actinomycetemcomitans (Aa) is 0.25 μg/mL (Takahashi et al., 2006).”
From Minocycline-loaded PLGA electrospun membrane prevents alveolar bone loss in experimental peridontitis (2020) · cites this paper as Okamoto-Shibayama et al., 2017
In the citing paper
“Minocycline is a commonly used drug for adjunctive therapy in periodontal disease.”
From Facile minocycline deployment in gingiva using a dissolvable microneedle patch for the adjunctive treatment of periodontal disease (2025) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Communication among Oral Bacteria
Kolenbrander, P. E., Andersen, R. N., Blehert, D. S., Egland, P. G., Foster, J. S., & Palmer, R. J. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.3.486-505.2002 · Cited by 1,022
Jepsen, K., & Jepsen, S. (2016) · Periodontology 2000 · doi:10.1111/prd.12121 · Cited by 306
Stamm, L. V., & Bergen, H. L. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.806-807.2000 · Cited by 123
Research works printed but not linked: 58
- Radolf, 2016, Treponema pallidum, the syphilis spirochete: making a living as a stealth pathogen, Nat. Rev. Microbiol., 14, 744, 10.1038/nrmicro.2016.141 · DOI · Paper page
- Demirkan, 2006, Characterization of a spirochaete isolated from a case of bovine digital dermatitis, J. Appl. Microbiol., 101, 948, 10.1111/j.1365-2672.2006.02976.x · doi:10.1111/j.1365-2672.2006.02976.x
- Sela, 2001, Role of Treponema denticola in periodontal diseases, Crit. Rev. Oral Biol. Med., 12, 399, 10.1177/10454411010120050301 · DOI · Paper page
- Holt, 2005, Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the “red complex”, a prototype polybacterial pathogenic consortium in periodontitis, Periodontol. 2000, 38, 72, 10.1111/j.1600-0757.2005.00113.x · DOI · Paper page
- Socransky, 1998, Microbial complexes in subgingival plaque, J. Clin. Periodontol., 25, 134, 10.1111/j.1600-051X.1998.tb02419.x · DOI · Paper page
- Simonson, 1988, Quantitative relationship of Treponema denticola to severity of periodontal disease, Infect. Immun., 56, 726, 10.1128/IAI.56.4.726-728.1988 · DOI · Paper page
- Ishihara, 2010, Virulence factors of Treponema denticola, Periodontol. 2000, 54, 117, 10.1111/j.1600-0757.2009.00345.x · DOI
- Ellen, 2005, Spirochetes at the forefront of periodontal infections, Periodontol. 2000, 38, 13, 10.1111/j.1600-0757.2005.00108.x · DOI · Paper page
- Takeuchi, 2001, Treponema socranskii, Treponema denticola, and Porphyromonas gingivalis are associated with severity of periodontal tissue destruction, J. Periodontol., 72, 1354, 10.1902/jop.2001.72.10.1354 · DOI · Paper page
- Lai, 1986, Serum IgA and IgG antibodies to Treponema vincentii and Treponema denticola in adult periodontitis, juvenile periodontitis and periodontally healthy subjects, J. Clin. Periodontol., 13, 752, 10.1111/j.1600-051X.1986.tb00878.x · doi:10.1111/j.1600-051x.1986.tb00878.x
- Tomita, 2014, Effects of systemic administration of sitafloxacin on subgingival microflora and antimicrobial susceptibility profile in acute periodontal lesions, Microb. Pathog., 71–72, 1, 10.1016/j.micpath.2014.04.003 · DOI
- Tomita, 2015, Changes in antimicrobial susceptibility profile and prevalence of quinolone low-sensitive strains in subgingival plaque from acute periodontal lesions after systemic administration of sitafloxacin, Microb. Pathog., 79, 41, 10.1016/j.micpath.2015.01.005 · doi:10.1016/j.micpath.2015.01.005
- Slots, 2002, Systemic antibiotics in the treatment of periodontal disease, Periodontol. 2000, 28, 106, 10.1034/j.1600-0757.2002.280106.x · DOI · Paper page
- Haas, 2008, Azithromycin as an adjunctive treatment of aggressive periodontitis: 12-months randomized clinical trial, J. Clin. Periodontol., 35, 696, 10.1111/j.1600-051X.2008.01254.x · DOI
- Feres, 1999, Systemic doxycycline administration in the treatment of periodontal infections. Effect on the subgingival microbiota, J. Clin. Periodontol., 26, 775, 10.1111/j.1600-051X.1999.tb02520.x · DOI
- Saito, 1994, Locally delivered minocycline and guided tissue regeneration to treat post-juvenile periodontitis. A case report, J. Periodontol., 65, 835, 10.1902/jop.1994.65.9.835 · doi:10.1902/jop.1994.65.9.835
- Nakajima, 2012, Effects of systemic sitafloxacin on periodontal infection control in elderly patients, Gerodontol, 29, e1024, 10.1111/j.1741-2358.2011.00605.x · DOI
- Pradeep, 2015, Clinical and microbiological effects of levofloxacin in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial, J. Clin. Invest. Dent., 6, 170, 10.1111/jicd.12091 · DOI
- Keating, 2011, Sitafloxacin: in bacterial infections, Drugs, 71, 731, 10.2165/11207380-000000000-00000 · DOI
- Chan, 1993, Treponema denticola (ex Brumpt 1925) sp. nov., nom. rev., and identification of new spirochete isolates from periodontal pockets, Int. J. Syst. Bacteriol., 43, 196, 10.1099/00207713-43-2-196 · DOI
- Weinberg, 1990, Interaction of Treponema denticola TD-4, GM-1, and MS25 with human gingival fibroblasts, Infect. Immun., 58, 1720, 10.1128/IAI.58.6.1720-1729.1990 · doi:10.1128/iai.58.6.1720-1729.1990
- Simbert RM, 1984, Treponema socranskii sp. nov., Treponema socranskii subsp. socranskii subsp. nov., Treponema socranskii subsp. buccale subsp. nov., and Treponema socranskii subsp. paredis subsp. nov. Isolated from the human periodontia, Int. J. Syst. Bacteriol., 179, 457, 10.1099/00207713-34-4-457 · doi:10.1099/00207713-34-4-457
- Mangan, 1982, In vitro lymphocyte blastogenic responses and titers of humoral antibodies from periodontitis patients to oral spirochete isolates, Infect. Immun., 37, 445, 10.1128/IAI.37.2.445-451.1982 · DOI
- Ohta, 1986, Purification and characterization of an enzyme produced by Treponema denticola capable of hydrolyzing synthetic trypsin substrates, Infect. Immun., 53, 213, 10.1128/IAI.53.1.213-220.1986 · DOI · Paper page
- Ishihara, 1995, Cloning and expression of a neutral phosphatase gene from Treponema denticola, Infect. Immun., 63, 1147, 10.1128/IAI.63.4.1147-1152.1995 · doi:10.1128/iai.63.4.1147-1152.1995
- Martin, 1972, In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens, Antimicrob. Agents Chemother., 1, 148, 10.1128/AAC.1.2.148 · doi:10.1128/aac.1.2.148
- Tresse, 1995, The role of oxygen limitation in the resistance of agar-entrapped, sessile-like Escherichia coli to aminoglycoside and beta-lactam antibiotics, J. Antimicrob. Chemother., 36, 521, 10.1093/jac/36.3.521 · DOI
- Katoh, 2016, A simple method to control over-alignment in the MAFFT multiple sequence alignment program, Bioinformatics, 32, 1933, 10.1093/bioinformatics/btw108 · DOI · Paper page
- Gomi, 2007, Effects of full-mouth scaling and root planing in conjunction with systemically administered azithromycin, J. Periodontol., 78, 422, 10.1902/jop.2007.060247 · DOI
- Veloo, 2012, Antibiotic susceptibility profiles of oral pathogens, Int. J. Antimicrob. Agents, 40, 450, 10.1016/j.ijantimicag.2012.07.004 · DOI
- Eickholz, 2002, Non-surgical periodontal therapy with adjunctive topical doxycycline: a double-blind randomized controlled multicenter study, J. Clin. Periodontol., 29, 108, 10.1034/j.1600-051x.2002.290204.x · DOI
- Goodson, 2007, Minocycline HCl microspheres reduce red-complex bacteria in periodontal disease therapy, J. Periodontol., 78, 1568, 10.1902/jop.2007.060488 · DOI
- Walker, 1987, Penicillin-degrading enzymes in sites associated with adult periodontitis, Oral Microbiol. Immunol., 2, 129, 10.1111/j.1399-302X.1987.tb00276.x · DOI
- Rams, 2013, Prevalence of beta-lactamase-producing bacteria in human periodontitis, J. Periodontal Res., 48, 493, 10.1111/jre.12031 · DOI
- Hardham, 2000, Antibiotic selective markers and spirochete genetics, J. Mol. Microbiol. Biotechnol., 2, 425
- Li, 1996, Development of a gene transfer system in Treponema denticola by electroporation, Oral Microbiol. Immunol., 11, 161, 10.1111/j.1399-302X.1996.tb00352.x · DOI
- Li, 2015, Kanamycin resistance cassette for genetic manipulation of Treponema denticola, Appl. Environ. Microbiol., 81, 4329, 10.1128/AEM.00478-15 · doi:10.1128/aem.00478-15
- Seshadri, 2004, Comparison of the genome of the oral pathogen Treponema denticola with other spirochete genomes, Proc. Natl. Acad. Sci. U.S.A., 101, 5646, 10.1073/pnas.0307639101 · DOI · Paper page
- Kuriyama, 2000, Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections, Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 90, 600, 10.1067/moe.2000.109639 · doi:10.1067/moe.2000.109639
- van Winkelhoff, 2005, Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in The Netherlands and Spain, J. Clin. Periodontol., 32, 893, 10.1111/j.1600-051X.2005.00782.x · DOI · Paper page
- Hosaka, 2010, Antimicrobial activity of Sitafloxiacin against periodontopathic bacteria, J. Jpn. Assoc. Periodontol., 52, 239, 10.2329/perio.52.239 · doi:10.2329/perio.52.239
- Nakajima, 2016, Microbiological and clinical effects of sitafloxacin and azithromycin in periodontitis patients receiving supportive periodontal therapy, Antimicrob. Agents Chemother., 60, 1779, 10.1128/AAC.02575-15 · DOI
- Kasai, 2014, Clinical and microbiological effects of systemic sitafloxacin administration in the treatment of acute periodontal lesions, J. Jpn. Assoc. Periodontol., 56, 39, 10.2329/perio.56.39 · DOI
- Wang, 1993, Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations, Antimicrob. Agents Chemother., 37, 457, 10.1128/AAC.37.3.457 · DOI · Paper page
- Takiff, 1994, Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations, Antimicrob. Agents Chemother., 38, 773, 10.1128/AAC.38.4.773 · DOI · Paper page
- Korten, 1994, Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis, Antimicrob. Agents Chemother., 38, 2091, 10.1128/AAC.38.9.2091 · DOI
- Yoshida, 1990, Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli, Antimicrob. Agents Chemother., 34, 1271, 10.1128/AAC.34.6.1271 · DOI · Paper page
- Heisig, 1994, Characterization of fluoroquinolone-resistant mutants of Escherichia coli selected in vitro, Antimicrob. Agents Chemother., 38, 1284, 10.1128/AAC.38.6.1284 · DOI
- Ito, 1994, Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus, Antimicrob. Agents Chemother., 38, 2014, 10.1128/AAC.38.9.2014 · DOI · Paper page
- Sreedharan, 1990, DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli, J. Bacteriol., 172, 7260, 10.1128/jb.172.12.7260-7262.1990 · DOI · Paper page
- Yonezawa, 1995, DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa, Antimicrob. Agents Chemother., 39, 1970, 10.1128/AAC.39.9.1970 · doi:10.1128/aac.39.9.1970
- Oh, 2001, gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains, Antimicrob. Agents Chemother., 45, 1977, 10.1128/AAC.45.7.1977-1981.2001 · DOI
- Inagaki, 2016, Treponema denticola invasion into human gingival epithelial cells, Microb. Pathog., 94, 104, 10.1016/j.micpath.2016.01.010 · doi:10.1016/j.micpath.2016.01.010
- Lamont, 1995, Porphyromonas gingivalis invasion of gingival epithelial cells, Infect. Immun., 63, 3878, 10.1128/IAI.63.10.3878-3885.1995 · DOI · Paper page
- Saito, 2008, Fusobacterium nucleatum enhances invasion of human gingival epithelial and aortic endothelial cells by Porphyromonas gingivalis, FEMS Immunol, Med. Microbiol., 54, 349
- Johnson, 2008, Persistence of extracrevicular bacterial reservoirs after treatment of aggressive periodontitis, J. Periodontol., 79, 2305, 10.1902/jop.2008.080254 · DOI
- Lai, 2013, Azithromycin kills invasive Aggregatibacter actinomycetemcomitans in gingival epithelial cells, Antimicrob. Agents Chemother., 57, 1347, 10.1128/AAC.02558-12 · doi:10.1128/aac.02558-12
- Lai, 2016, Relative effectiveness of azithromycin in killing intracellular Porphyromonas gingivalis, Clin. Exp. Dent. Res., 1, 35, 10.1002/cre2.17 · DOI
Cited by
Ma, Y., Song, J., Almassri, H. N. S., Zhang, D., Zhang, T., Cheng, Y., & Wu, X. (2020) · Drug Delivery · doi:10.1080/10717544.2019.1709921 · Cited by 51
Zhang, T., Qiu, Y., Song, J., Zhou, P., Liao, H., Cheng, Y., & Wu, X. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1902020 · Cited by 36
Li, H., Wen, X., Gong, X., Wu, Y., Zhao, P., Zhang, Y., Sha, Z., Chang, H., & Chen, X. (2025) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10730 · Cited by 17
Metadata
- Authors
- Okamoto-Shibayama, K., Sekino, J., Yoshikawa, K., Saito, A., & Ishihara, K.
- Venue
- Anaerobe
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 48
- Pages
- 242-248
- ISSN
- 1075-9964
- Cited by
- 15
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- Japan Society for the Promotion of Science (15K11023, 16K11841)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antimicrobial susceptibility profiles of oral Treponema species. https://app.cochat.ai/papers/10.1016/j.anaerobe.2017.10.005
- The paper
- Okamoto-Shibayama, K., Sekino, J., Yoshikawa, K., Saito, A., & Ishihara, K. (2017). Antimicrobial susceptibility profiles of oral Treponema species. Anaerobe. https://doi.org/10.1016/j.anaerobe.2017.10.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.